Coronavirus channel feed

How to man­u­fac­ture Covid-19 vac­cines with­out the help of J&J, Pfiz­er or Mod­er­na? Bi­ol­yse sees the dif­fi­cul­ties up close

4 years ago
FDA+

Covid-19 roundup: EU to sup­port vac­cine man­u­fac­tur­ing ef­forts in Africa — re­port; Sput­nik Light ap­proved for use in Venezuela

4 years ago

Sanofi, Glax­o­SmithK­line jump back in­to the PhI­II race for a Covid vac­cine — as the win­ners con­gre­gate be­hind the fin­ish line

4 years ago
R&D

BAR­DA slows its $9B en­gine for new Covid-19 ther­a­peu­tics

4 years ago
R&D

Covid-19 roundup: High­er an­ti­body counts seen in spaced-out vac­cine in­ter­vals — study; Roche CEO com­pares IP waiv­er to East Ger­man 'ex­per­i­ments'

4 years ago

Mod­er­na taps in­to Aus­tralia with Covid-19 boost­er deal and the po­ten­tial for lo­cal man­u­fac­tur­ing

5 years ago
Manufacturing

Brazil­ian Covid vari­ant in Illi­nois leads to a pause in ship­ments of Lil­ly’s mAb com­bo

5 years ago
FDA+

In the lat­est chap­ter of Emer­gent saga, CEO Bob Kramer will ad­dress US House sub­com­mit­tee on plant woes

5 years ago
Manufacturing

Covid-19 man­u­fac­tur­ing roundup: Emer­gent starts clean-up ef­fort af­ter dis­as­trous Form 483; Eli Lil­ly ex­pands li­cens­es for In­di­an part­ners

5 years ago
Manufacturing

Covid-19 roundup: Study finds that mix­ing Covid-19 vac­cines could lead to more fre­quent side ef­fects; CDC ad­comm votes unan­i­mous­ly in fa­vor of Pfiz­er/BioN­Tech shot in ado­les­cents

5 years ago

Pfiz­er calls pro­posed IP waiv­er for Covid vac­cines a 'dis­trac­tion' from find­ing re­al so­lu­tions on ac­cess

5 years ago
Pharma

Covid-19 roundup: Pfiz­er CEO Bourla to write book about vac­cine arms race; Chi­nese mR­NA shot set for PhI­II tri­al in Mex­i­co

5 years ago

Covid-19 roundup: FDA au­tho­rizes Pfiz­er/BioN­Tech vac­cine for 12- to 15-year-olds; No­vavax shares sink as com­pa­ny de­lays vac­cine time­line

5 years ago

Covid-19 roundup: No­vavax may not go to FDA un­til June at ear­li­est — re­port; Bourla push­es back against IP waiv­er in pub­lic let­ter

5 years ago

Covid-19 roundup: Pfiz­er sub­mits vac­cine for full ap­proval; Merkel op­pos­es Biden pro­pos­al to sus­pend IP for vac­cines

5 years ago
Pharma

EMA safe­ty com­mit­tee seeks more in­fo on heart in­flam­ma­tion fol­low­ing Pfiz­er Covid-19 vac­cine

5 years ago
FDA+

Mod­er­na CEO brush­es off US sup­port for IP waiv­er, eyes more than $19B in Covid-19 vac­cine sales in 2021

5 years ago
Manufacturing

Covid-19 roundup: Pfiz­er/BioN­Tech do­nate their vac­cine to the Tokyo Olympics; No­vavax, Pfiz­er/BioN­Tech vac­cines ap­pear to be less ef­fec­tive against vari­ants

5 years ago

Mod­er­na says Covid-19 vac­cine boost­er in­creased im­mune re­sponse against vari­ants of con­cern

5 years ago
R&D

Covid-19 man­u­fac­tur­ing roundup: Freez­er kits to store vac­cines de­liv­ered to Venezuela; UN chief weighs in on IP de­bate

5 years ago
Outsourcing
Manufacturing

An em­ploy­ee com­plaint at Eli Lil­ly's Branch­burg plant al­leges al­tered qual­i­ty con­trol docs amid FDA probe — re­port

5 years ago
Pharma

Ada­gio of­fers first peek at Covid-19 an­ti­body da­ta, with pre­ven­ta­tive num­bers that may ri­val mR­NA vac­cines

5 years ago
R&D

How much? Pfiz­er ex­pects to reap at least $26B from Covid vac­cine in 2021

5 years ago
R&D

Covid-19 roundup: EMA be­gins rolling re­view of first Chi­nese vac­cine; Af­ter 100% ef­fi­ca­cy tri­al, teenagers could be el­i­gi­ble for Pfiz­er's vac­cine next week

5 years ago
First page Previous page 27282930313233 Next page Last page
A service from the Financial Times